Digital therapists can help people with IBS.

Published Date: 02 Mar 2023

Although further research is needed, these tools may improve clinical management.

Read Full News

Latest News

Analysis: 'Breakneck' Ebola Epidemic Outpaces World Response

Health teams are racing to find thousands of people ⁠who may have been exposed to the virus while also grappling with myriad challenges that make it difficult to contain.

US, Mexico, Canada Announce Ebola-related Travel Measures Ahead of World Cup

The United States, Mexico and Canada on Thursday announced aligned public health travel measures for people coming ⁠from African regions at the greatest risk from Ebola,...

Should North Africa Be Concerned About Ebola?

Yes, but don’t panic, say experts.

Kenyan Court Orders Suspension of US Plan for Ebola Quarantine Facility

A Kenyan court has ordered the temporary suspension of a plan for the United States to set up an Ebola quarantine facility in the country after a lawsuit argued the site...

House Dust Mite Immunotherapy May Prevent Allergies in Kids

Preventive house dust mite sublingual immunotherapy in sensitized, symptom-free preschoolers may safely induce blocking antibodies, reduce allergic responses, and limit new sensitizations.

Don’t Ignore Mild Asthma in Children

Mild childhood asthma is often missed, risking impaired lung growth, fixed airflow obstruction and future COPD; early diagnosis and control can prevent lasting harm.

Todays Updates

Psychotropics Linked to Increased BMI, CVD Risk

Psychotropics are associated with increased BMI, and users with a high BMI genetic risk score and an unhealthy lifestyle have triple the risk for CVD, new research shows.

Tafasitamab Combo Boosts R-CHOP in Frontline DLBCL

Tafasitamab and lenalidomide are likely to be approved with R-CHOP for frontline DLBCL, but with bispecific antibodies on the horizon, the role of the combination is uncertain.

Abemaciclib Slows Progression of Advanced Liposarcoma

In a phase 3 trial of patients with dedifferentiated liposarcoma, the CDK4/6 inhibitor extended progression-free survival more than sixfold.

Therapy Combo Improves Radiographic PFS in Prostate Cancer

A phase 3 trial evaluates a PARP inhibitor or placebo plus an androgen pathway inhibitor to treat men with advanced prostate cancer associated with genetic changes.

Teclistamab Alone Ups Previously Treated Myeloma Survival

In the first phase 3 trial of teclistamab monotherapy, the bispecific antibody was associated with better PFS and OS than standard regimens in relapsed or refractory multiple myeloma.

Trial Supports Ivonescimab and Chemo for NSCLC Survival

A phase 3 trial evaluates the safety and efficacy of an investigational bispecific antibody with chemotherapy compared to standard treatment in advanced squamous NSCLC.

Asandeutertinib Tops Osimertinib for NSCLC With Brain Mets

In an interim analysis of a randomized phase 2 trial, asandeutertinib improved intracranial response and intracranial PFS vs osimertinib in patients with EGFR-mutated NSCLC with brain metastases.

Todays Updates

Psychotropics Linked to Increased BMI, CVD Risk

Psychotropics are associated with increased BMI, and users with a high BMI genetic risk score and an unhealthy lifestyle have triple the risk for CVD, new research shows.

Tafasitamab Combo Boosts R-CHOP in Frontline DLBCL

Tafasitamab and lenalidomide are likely to be approved with R-CHOP for frontline DLBCL, but with bispecific antibodies on the horizon, the role of the combination is uncertain.

Abemaciclib Slows Progression of Advanced Liposarcoma

In a phase 3 trial of patients with dedifferentiated liposarcoma, the CDK4/6 inhibitor extended progression-free survival more than sixfold.

Therapy Combo Improves Radiographic PFS in Prostate Cancer

A phase 3 trial evaluates a PARP inhibitor or placebo plus an androgen pathway inhibitor to treat men with advanced prostate cancer associated with genetic changes.

Teclistamab Alone Ups Previously Treated Myeloma Survival

In the first phase 3 trial of teclistamab monotherapy, the bispecific antibody was associated with better PFS and OS than standard regimens in relapsed or refractory multiple myeloma.

Trial Supports Ivonescimab and Chemo for NSCLC Survival

A phase 3 trial evaluates the safety and efficacy of an investigational bispecific antibody with chemotherapy compared to standard treatment in advanced squamous NSCLC.

Asandeutertinib Tops Osimertinib for NSCLC With Brain Mets

In an interim analysis of a randomized phase 2 trial, asandeutertinib improved intracranial response and intracranial PFS vs osimertinib in patients with EGFR-mutated NSCLC with brain metastases.

Latest News

Health teams are racing to find thousands of people ⁠who may have been exposed to the virus while also grappling with myriad challenges that make it difficult to contain.

The United States, Mexico and Canada on Thursday announced aligned public health travel measures for people coming ⁠from African regions at the greatest risk from Ebola,...

Yes, but don’t panic, say experts.

A Kenyan court has ordered the temporary suspension of a plan for the United States to set up an Ebola quarantine facility in the country after a lawsuit argued the site...

Preventive house dust mite sublingual immunotherapy in sensitized, symptom-free preschoolers may safely induce blocking antibodies, reduce allergic responses, and limit new sensitizations.

Mild childhood asthma is often missed, risking impaired lung growth, fixed airflow obstruction and future COPD; early diagnosis and control can prevent lasting harm.

News All Time

Simple Blood Count May Help Predict Flare-Up Risk in Asthma

Blood eosinophil counts may help predict the risk for exacerbations in patients with asthma, but fractional exhaled nitric oxide shows mixed results and may be less useful in COPD.

Kidney Biopsy May Be Safe, Guiding Treatment in Pregnancy

A French study shows that kidney biopsy during early pregnancy appears safe — with only one patient with serious bleeding requiring transfusion — and often guides therapeutic decisions.

Insulet Flags Dosing Defect in Some Omnipod Devices, Sees Up to $50 Million Cost

Insulet said on Tuesday it is carrying out a voluntary correction of certain insulin pump ⁠pods across its Omnipod product lines after identifying a manufacturing issue that...

Canada, Bahamas Imposes Ebola-related Travel Bans

Canada and the Bahamas said on Tuesday they will temporarily ban residents from the ⁠Democratic Republic of the Congo, Uganda and South Sudan amid an Ebola outbreak.

US Planning Quarantine Facility in Kenya for Citizens Exposed to Ebola, Sources Say

The U.S. is discussing with Kenya opening a facility there to quarantine American citizens who become exposed to the Ebola outbreak centered in the Democratic Republic of...

Impact of US Population Aging on Hospital Medicine

As Americans get older, the impact often lands on hospitalists and hospitals.

New Case in Spain Brings Hantavirus Cases From Outbreak to 13

The number of cases of ⁠Hantavirus linked to a cruise ship at the centre of an ⁠outbreak has increased to 13, according to the head of the WHO.

Prevalence of Tree Nut Allergies in Dutch Children

The prevalence of tree nut allergies is nearly 6% in Dutch children aged 1-12 years, with fewer than 1 in 4 introduced to tree nuts before 12 months of age.

Analgesic Allergies Linked to Pregnancy Risks

Maternal nonnarcotic analgesic allergy labels are linked to a 60% higher risk for eclampsia and 20% higher risk for preterm birth.

Early Food Allergy Not Linked to Teen Eating Problems

Food allergy in early childhood may not increase the odds of food fussiness during adolescence.

Measuring Drug Hypersensitivity in Pediatric Urticaria

Drug hypersensitivity was found in half of a group of children with suspected hypersensitivity and chronic spontaneous urticaria.

Alternaria Allergy in Youth Signals Lasting Asthma Risk

Sensitization to Alternaria fungus often starts in adolescence and is linked to increased risks for persistent asthma and rhinitis, a study finds.

EU Panel Backs Wider Uses for Cancer Drugs

The EMA has backed new and expanded uses for multiple cancer drugs, signaling a push toward biomarker-driven, earlier-line care.

Interface Lets Paralyzed Patient 'Type' Faster than Ever

A paralyzed patient nearly matched the words per minute the average person can type on their phone, with 95% accuracy. See how brain-computer interface has improved.

Doctors Warn Social Media Poses Smoking-Level Health Risk

The Academy of Medical Royal Colleges has called for routine clinical screening of children's social media use in evidence to the government's online safety consultation.

FDA Approves Bulevirtide for Hepatitis Delta Virus

Bulevirtide (Hepcludex; Gilead Sciences, Inc.) is the first FDA-approved treatment for chronic hepatitis delta virus infection.

Recommended News For You

The New Canadian Guidelines for Drinking at High Risk, AUD.

Significant differences in breast cancer care still exist, but surgeons can change.

Study supports routine brain MRI screening in asymptomatic late-stage breast cancer patients

Clinical trial results show low-intensity therapy can achieve positive outcomes for certain pediatric leukemia subtypes

Anticoagulation for 12 months has been found to improve outcomes in cancer patients with minor blood clots.

Prostate cancer therapies: AI-based image analysis detects early organ damage

Study: For predicting breast cancer, AI performs better than traditional risk models.

Recommended Articles For You

Molecular & Genetic Oncology: Emerging Frontiers in 2025 

The Algorithmic Revolution: How AI is Reshaping Precision Oncology from Bench to Bedside 

LncRNAs in Cancer: Shaping Tumor Progression & Paving New Paths for Treatment 

Understanding Verrucous Carcinoma: Symptoms, Diagnosis, and Treatment Options 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Big Comeback for Myeloma Drug; DIY Cancer Therapy; Gut Clues to Bladder Cancer

2.

In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.

3.

According to a study, white Americans are overdiagnosing melanoma at an alarming rate.

4.

Thriving while surviving: Understanding the social needs of cancer survivors

5.

In 18 States, alcohol exclusion laws are still in effect.

1.

Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth 

2.

Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights

3.

Understanding Drug-Induced Cardiotoxicity: Mechanisms, Impact, and Future Directions

4.

Exploring the Use of Bevacizumab in Treating Different Types of Cancers 

5.

Voices That Heal: Redefining Cancer Care Through Patient Insights and Partnership

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients

2.

Exploring the Hospitalization Burden in Refractory and Relapsed ALL

3.

The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot